By Lisa Kerner
Charlotte, N.C., July 10 - Emcure Pharmaceuticals Ltd. said The Blackstone Group, a private investment firm, and its affiliates will invest $50 million in the company.
The transaction is expected to close by August.
No further details were disclosed.
"We look forward to their active participation in our board and their help with strategic relationships and acquisitions given their expertise and network in the industry," Emcure managing director Satish Mehta said in a company news release.
Emcure is a vertically integrated pharmaceutical company based in Pune, India.
| Issuer: | Emcure Pharmaceuticals Ltd.
|
| Issue: | Private funding
|
| Amount: | $50 million
|
| Investor: | The Blackstone Group and affiliates
|
| Announcement date: | July 10
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
